InnoCan Pharma Corp. operates as a pharmaceutical tech company. It operates through the Online Sales and Other Operations segments. The Online Sales segment engages in the development of non-CBD personal care and beauty products in the United States for online platforms such as Amazon, and other e-commerce retail sales. The Other Operations segment involves in the development of several drug delivery platforms, combining cannabinoids with other pharmaceutical ingredients as well as the development and sale of CBD-integrated topical products. The company was founded in October 2017 and is headquartered in Alberta, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of InnoCan Pharma Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. InnoCan Pharma Corp market cap is $854,800.00.
What is the 52-week high for InnoCan Pharma Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. InnoCan Pharma Corp 52 week high is $16.90 as of September 07, 2025.
What is the 52-week low for InnoCan Pharma Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. InnoCan Pharma Corp 52 week low is $0.19 as of September 07, 2025.
What is InnoCan Pharma Corp stock price today?
InnoCan Pharma Corp stock price today is $13.00.
What was InnoCan Pharma Corp stock price yesterday?
InnoCan Pharma Corp stock price yesterday was $12.35.
What is the PE ratio of InnoCan Pharma Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. InnoCan Pharma Corp’s P/E ratio is -0.38.
What is the Price-to-Book ratio of InnoCan Pharma Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. InnoCan Pharma Corp P/B ratio is 0.1489.
What is the 50-day moving average of InnoCan Pharma Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. InnoCan Pharma Corp 50-day moving average is $13.95.
